Using undercover footage, FRONTLINE presents the gripping, first-hand accounts of women who escaped the brutal reign of ISIS -- and follows an underground network that's helping them escape.
FRONTLINE investigates the rise of deadly drug-resistant bacteria.
(54:11) FRONTLINE investigates the rise of deadly drug-resistant bacteria.
Meet the "Nightmare Bacteria" View images of some of the more troubling bugs that are out there.
The Global Reach of ResistanceMore from global health expert Ramanan Laxminarayan on the risks posed by antibiotic resistance.
More From Dr. Brad SpellbergAntibiotic resistance is "everyone's fault," says the author of Rising Plaugue.
More From Dr. John RexThe drug pipeline is "very, very thin," says the AstraZeneca executive.
"These Are Not Ruthless Decisions" More from Pfizer executive Dr. Charles Knirsch.
"We've Reached the End of Antibiotics" More from Dr. Arjun Srinivasan of the CDC.
Who's Working to Fix the Crisis? The problem is clear: There aren't enough new antibiotics. The question is, why aren't more drug companies filling the gap?
Who's Tracking the "Nightmare Bacteria"? The threat is growing, yet the U.S. has yet to develop a strategy for stemming the spread of "nightmare bacteria."
An ambitious five-year plan aims to stem the spread of potentially deadly drug-resistant bacteria, but some critics say the effort does not go far enough.
The largest outbreak on record of one so-called “nightmare bacteria” is fueling alarm among public health officials about the spread of potentially lethal drug-resistant infections.
Join a live chat on “Hunting the Nightmare Bacteria” with producer Rick Young, correspondent David Hoffman, infectious disease expert Dr. Sean Elliot, and guest questioner Maggie Koerth-Baker from BoingBoing. You can leave a question now.
The problem is clear: there aren’t enough new antibiotics. The question is why aren’t more pharmaceutical companies filling the gap — and what’s being done to try to reverse this trend?
Funding for FRONTLINE is provided through the support of PBS viewers and by the Corporation for Public Broadcasting.
Major funding for FRONTLINE is provided by John D. and Catherine T. MacArthur Foundation.
Additional funding is provided by the Park Foundation, the Ford Foundation, Wyncote Foundation,
and the FRONTLINE Journalism Fund with major support from Jon and Jo Ann Hagler on behalf of the Jon L. Hagler Foundation.